Stem Cell Manufacturing Market Value Chain, Future Analysis, Industry Growth by 2030
Stem Cell Manufacturing Market - Highlights
The Stem Cell Manufacturing Industry is expected to have accounted for the market value of USD 10.8 billion in 2022 and is projected to grow at a Stem Cell Manufacturing Market size of 6.6% over the assessment period. Stem cell manufacturing is a process in which cells from the bone marrow or peripheral blood cells are isolated and cultured in a culture dish containing nutrient media. Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment period.
According to a report published by Lozier Institute in November 2022, there are nearly 3,500 ongoing or completed clinical trials (in patients) using adult stem cells, as listed in the National Institutes of Health/FDA-approved database. On the other hand, high costs associated with stem cell research and stringent government regulations may hinder the market growth during the forecast period.
Currently, the global market is dominated by numerous prominent players. The key players in the market are engaged in product approvals, strategic collaborations and acquisitions to strengthen their market position. For instance, in April 2022, STEMCELL Technologies Inc. announced a government funding worth USD 45 million for advanced manufacturing facility to manufacture its stem cell products at high regulatory compliance standards.
Worldwide Segmentation:
The global stem cell manufacturing market has been segmented into product, application and end user.The market, on the basis of product, has been segmented into stem cell lines, instruments, culture media and consumables. Stem cell lines are further segmented into hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), induced pluripotent stem cell (iPSC), embryonic stem cell (ESC) and
Stem Cell Manufacturing Market - Highlights
The Stem Cell Manufacturing Industry is expected to have accounted for the market value of USD 10.8 billion in 2022 and is projected to grow at a Stem Cell Manufacturing Market size of 6.6% over the assessment period. Stem cell manufacturing is a process in which cells from the bone marrow or peripheral blood cells are isolated and cultured in a culture dish containing nutrient media. Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment period.
According to a report published by Lozier Institute in November 2022, there are nearly 3,500 ongoing or completed clinical trials (in patients) using adult stem cells, as listed in the National Institutes of Health/FDA-approved database. On the other hand, high costs associated with stem cell research and stringent government regulations may hinder the market growth during the forecast period.
Currently, the global market is dominated by numerous prominent players. The key players in the market are engaged in product approvals, strategic collaborations and acquisitions to strengthen their market position. For instance, in April 2022, STEMCELL Technologies Inc. announced a government funding worth USD 45 million for advanced manufacturing facility to manufacture its stem cell products at high regulatory compliance standards.
Worldwide Segmentation:
The global stem cell manufacturing market has been segmented into product, application and end user.The market, on the basis of product, has been segmented into stem cell lines, instruments, culture media and consumables. Stem cell lines are further segmented into hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), induced pluripotent stem cell (iPSC), embryonic stem cell (ESC) and
10:44 AM - Dec 13, 2023 (UTC)